Balance Sheet - Enliven Therapeutics, Inc. (ELVN)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | |
|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 0.46 | 0.31 | 0.25 | 0.08 | 0.15 | 0.09 | 0.03 | 0.01 | 0.01 |
| Other current assets | 0.01 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total current assets | 0.47 | 0.32 | 0.27 | 0.08 | 0.11 | 0.09 | 0.03 | 0.01 | 0.01 |
| Total non-current assets | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | ||
| Total assets | 0.48 | 0.33 | 0.27 | 0.08 | 0.11 | 0.09 | 0.03 | 0.01 | 0.01 |
| Total current liabilities | 0.02 | 0.02 | 0.03 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
| Total non-current liabilities | 0.00 | 0.00 | 0.00 | 0.15 | 0.00 | 0.00 | 0.00 | 0.03 | 0.00 |
| Total liabilities | 0.02 | 0.02 | 0.03 | 0.16 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
| Total stockholders' equity | 0.46 | 0.31 | 0.25 | -0.08 | 0.11 | 0.08 | -0.05 | -0.03 | -0.02 |
| Common shares outstanding | 57 | 47 | 36 | 6 | 8 | 4 | 4 | 4 | 4 |
Show Quarterly Balance Sheet
Balance Sheet - Enliven Therapeutics, Inc. (ELVN)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | Dec-19 | Sep-19 | Jun-19 | Mar-19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 0.45 | 0.46 | 0.48 | 0.49 | 0.29 | 0.31 | 0.29 | 0.31 | 0.32 | 0.25 | 0.26 | 0.28 | 0.29 | 0.08 | 0.09 | 0.06 | 0.07 | 0.15 | 0.10 | 0.07 | 0.08 | 0.09 | 0.10 | 0.11 | 0.11 | 0.03 | 0.00 | 0.00 | 0.00 |
| Other current assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Total current assets | 0.46 | 0.47 | 0.48 | 0.50 | 0.29 | 0.32 | 0.30 | 0.32 | 0.34 | 0.27 | 0.27 | 0.28 | 0.30 | 0.08 | 0.09 | 0.06 | 0.08 | 0.11 | 0.11 | 0.07 | 0.08 | 0.09 | 0.10 | 0.11 | 0.11 | 0.03 | |||
| Total non-current assets | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Total assets | 0.46 | 0.48 | 0.49 | 0.50 | 0.30 | 0.33 | 0.31 | 0.33 | 0.34 | 0.27 | 0.27 | 0.29 | 0.30 | 0.08 | 0.09 | 0.06 | 0.08 | 0.11 | 0.11 | 0.07 | 0.08 | 0.09 | 0.10 | 0.11 | 0.11 | 0.03 | |||
| Total current liabilities | 0.01 | 0.02 | 0.01 | 0.02 | 0.01 | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | |||
| Total non-current liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Total liabilities | 0.01 | 0.02 | 0.01 | 0.02 | 0.01 | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 | 0.01 | 0.01 | 0.01 | 0.16 | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | |||
| Total stockholders' equity | 0.45 | 0.46 | 0.48 | 0.49 | 0.29 | 0.31 | 0.29 | 0.30 | 0.32 | 0.25 | 0.26 | 0.28 | 0.29 | -0.08 | 0.08 | 0.06 | 0.07 | 0.11 | 0.10 | 0.06 | 0.08 | 0.08 | 0.09 | 0.11 | 0.11 | 0.03 | |||
| Common shares outstanding | 63 | 57 | 62 | 52 | 50 | 50 | 48 | 48 | 42 | 41 | 41 | 41 | 19 | 7 | 7 | 7 | 7 | 7 | 6 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |